Skip to main content

7 Result(s)

within Vincenzo Dadduzio Remove this filter

and

  1. Article

    Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

    An Online First version of this article was made available online at https://springer.longhoe.net/article/10.1007/s11523-020-00757-3 on 12 October 2020. Errors were s...

    Giulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, Caterina Vivaldi… in Targeted Oncology (2020)

    Download PDF (500 KB) View Article

  2. No Access

    Article

    Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

    Inflammation is a long-established hallmark of liver fibrosis and carcinogenesis. Eosinophils are emerging as crucial components of the inflammatory process influencing cancer development. The role of blood eo...

    Giulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, Caterina Vivaldi… in Targeted Oncology (2020)

  3. Article

    Open Access

    The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases

    Hepatic resection is the gold standard treatment for patients affected by liver-limited colorectal metastases. Reports addressing the impact of multidisciplinary team (MDT) evaluation on survival are controver...

    Michele Basso, Salvatore Corallo, Maria Alessandra Calegari… in Scientific Reports (2020)

    Download PDF (1141 KB) View Article

  4. Article

    Open Access

    CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer

    V600EBRAF mutated metastatic colorectal cancer (mCRC) is a subtype (10%) with overall poor prognosis, but the clinical experience suggests a great heterogeneity in survival. It is still unexplored the real distri...

    Fotios Loupakis, Paola Biason, Alessandra Anna Prete… in British Journal of Cancer (2019)

    Download PDF (389 KB) View Article

  5. No Access

    Article

    Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies

    Angiogenesis is an essential process for tumor growth and metastasis. Inhibition of angiogenesis as an anticancer strategy has shown significant results in a plethora of tumors. Anti-angiogenic agents are curr...

    Letizia Procaccio, Vera Damuzzo, Francesca Di Sarra, Alberto Russi… in Drug Safety (2019)

  6. No Access

    Article

    Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis

    Mutations of epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC) predict longer overall survival (OS) and response to EGFR tyrosine kinase inhibitors (TKIs). The clinical relevance of d...

    Sabrina Rossi, Ettore D’Argento, Michele Basso… in Molecular Diagnosis & Therapy (2016)

  7. No Access

    Article

    KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study

    Kirsten-Ras (KRAS) mutations are widely accepted negative predictive factors for anti-EGFR therapies in metastatic colorectal cancer (mCRC), while their prognostic significance is still under discussion.

    Vincenzo Dadduzio, Michele Basso, Sabrina Rossi… in Molecular Diagnosis & Therapy (2016)